Evaluation of Patient Analgesia After Bloc Serratus (TraumaThorax)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04123977|
Recruitment Status : Recruiting
First Posted : October 11, 2019
Last Update Posted : October 21, 2019
Thorax traumas are very common in severe traumatology, including road accidents, representing the second most frequent site (after head injury, according to the FIRST study). These thoracic lesions are the cause of many complications (pneumothorax, hemothorax, lung infections, atelectasis).
The national recommendations recommend the use of multi-modal analgesia with the use of regional loco anaesthesia for pain management and prevention of respiratory complications, including infectious complications. The loco-regional anaesthesia of choice is thoracic epidural or paravertebral block, but these techniques are not without risks, and are contraindicated in many situations (severe head trauma, patient under curative anticoagulation, pelvic trauma...).
The anterior Serratus block appears to be a quality localoregional anaesthesia in thoracic surgery, and a few cases in the literature have shown an interest in severe traumatology.
The investigators perform this anterior Serratus block almost systematically in patients with thoracic trauma in the Hautepierre surgical intensive care unit.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Evaluation of Patient Analgesia After Bloc Serratus for the Management of Thoracic Trauma|
|Actual Study Start Date :||October 1, 2019|
|Estimated Primary Completion Date :||October 2020|
|Estimated Study Completion Date :||October 2020|
- Retrospective analysis of analgesia after Bloc serratus [ Time Frame: Files analysed retrospectily from January 1st, 2018 to February 28, 2019 will be examined ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04123977
|Contact: Julien POTTECHER, MD, PhD||33 3 88 12 70 firstname.lastname@example.org|
|Contact: Kevin COGNE, MD||33 3.88 12 61 email@example.com|
|Service de Réanimation chirurgicale_ Hôpital de Hautepierre||Recruiting|
|Strasbourg, France, 67091|
|Contact: Julien POTTECHER, MD, PhD 33 3 88 12 70 95 firstname.lastname@example.org|
|Contact: Kevin COGNE, MD 33 3 88 12 61 55 email@example.com|
|Principal Investigator: Julien POTTECHER, MD, PhD|
|Sub-Investigator: Kevin COGNE, MD|
|Sub-Investigator: Paul BRUNET, MD|
|Study Director:||Julien POTTECHER, MD, PhD||University Hospital, Strasbourg, France|